Skip to main content

Beneficial ownership — 13D / 13G

87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
AQR CAPITAL MANAGEMENT LLC LATG Chenghe Acquisition I Co. Class A Ordinary Shares 13G/A 0% 2y
Flagship Ventures Fund V, L.P. SANA Sana Biotechnology, Inc. 13G/A 13% 2y
Venrock Healthcare Capital Partners III, L.P. VRDN Viridian Therapeutics, Inc.DE 13G/A 9.99% 2y
ForgePoint Cybersecurity GP-I, LLC ZFOX ZeroFox Holdings, Inc. Common Stock 13G/A 4.8% 2y
Kynam Capital Management, LP COGT Cogent Biosciences, Inc. 13G 6.8% 2y
V. PREM WATSA FRFHF Fairfax Financial Holdings Ltd 13G/A 9.8% 2y
Divisadero Street Capital Management, LP APYX Apyx Medical Corp 13G/A 0% 2y
MAVERICK CAPITAL LTD CRIS Curis Inc 13G/A 9.9% 2y
ARMISTICE CAPITAL, LLC BJDX Bluejay Diagnostics, Inc. 13G 9.99% 2y
Berkshire Hathaway Inc AAPL Apple Inc. 13G/A 5.8% 2y
Point72 Asset Management, L.P. ELEV Elevation Oncology, Inc. Common stock 13G/A 9.4% 2y
BROWN CAPITAL MANAGEMENT LLC ALRM Alarm.com Holdings, Inc. 13G/A 8.99% 2y
RA CAPITAL MANAGEMENT, L.P. HARP Harpoon Therapeutics, Inc. Common Stock 13G/A 9.99% 2y
FIR TREE CAPITAL MANAGEMENT LP CSTAF Constellation Acquisition Corp I 13G 6.42% 2y
FIR TREE CAPITAL MANAGEMENT LP GODN Golden Star Acquisition Corporation Ordinary Shares 13G 6.48% 2y
William Carlton Derrick WHLR Wheeler Real Estate Investment Trust, Inc. 13G/A 8.03% 2y
Vellar Opportunities Fund Master, Ltd. AAGR African Agriculture Holdings Inc. Common Stock 13G/A 4.86% 2y
METEORA CAPITAL, LLC NKGN NKGen Biotech, Inc. Common Stock 13G 7.3% 2y
Clal Insurance Enterprises Holdings Ltd BLZE Backblaze, Inc. 13G/A 0% 2y
Sculptor Capital LP TWOA two 13G/A 0% 2y
Venrock Healthcare Capital Partners III, L.P. APLT Applied Therapeutics, Inc. Common Stock 13G/A 9.99% 2y
T. Rowe Price Investment Management, Inc. SPXC SPX Technologies, Inc. 13G 5.4% 2y
Sio Capital Management, LLC MODD Modular Medical, Inc. 13G/A 9.99% 2y
AQR CAPITAL MANAGEMENT LLC RMCO Royalty Management Holding Corp 13G/A 0.9% 2y
Williiam Wei Wang VZIO VIZIO Holding Corp. 13G/A 39% 2y
RIVERNORTH CAPITAL MANAGEMENT, LLC BACA Berenson Acquisition Corp. I 13G/A 7.05% 2y
BIOTECHNOLOGY VALUE FUND L P CRNX Crinetics Pharmaceuticals, Inc. 13G/A 0% 2y
Empyrean Capital Partners, LP WPCA Warburg Pincus Capital Corporation I-A 13G/A 0% 2y
Alberta Investment Management Corp HAYW Hayward Holdings, Inc. 13G/A 0% 2y
Thomas A. James RJF Raymond James Financial Inc 13G/A 9.3% 2y
Alyeska Investment Group, L.P. TNXP Tonix Pharmaceuticals Holding Corp. 13G 9.99% 2y
Greenoaks Capital Partners LLC CVNA Carvana Co. 13G/A 5.3% 2y
PRICE T ROWE ASSOCIATES INC /MD/ NRIX Nurix Therapeutics, Inc. 13G/A 4.9% 2y
Fort Baker Capital Management LP UTAA UTA Acquisition Corporation Class A Ordinary Shares 13G/A 0% 2y
ORBIMED ADVISORS LLC MREO Mereo BioPharma Group plc 13G/A 0% 2y
PRICE T ROWE ASSOCIATES INC /MD/ TNYA Tenaya Therapeutics, Inc. 13G/A 6.7% 2y
AMERIPRISE FINANCIAL INC BUR Burford Capital Ltd 13G/A 4.21% 2y
TANG CAPITAL MANAGEMENT, LLC ELEV Elevation Oncology, Inc. Common stock 13G/A 9.99% 2y
Paradigm Biocapital Advisors LP OLMA Olema Oncology, Inc. 13G/A 14.3% 2y
PRICE T ROWE ASSOCIATES INC /MD/ EQH Equitable Holdings, Inc. 13G/A 8.2% 2y
Xinfeng Feng ATMC AlphaTime Acquisition Corp Ordinary Shares 13G 29.37% 2y
Aristotle Capital Management, LLC CTRA Coterra Energy Inc. 13G/A 4.85% 2y
Index Ventures Growth I (Jersey) L.P. SQSP Squarespace, Inc. 13G/A 0% 2y
SIT INVESTMENT ASSOCIATES INC PAI Western Asset Investment Grade Income Fund Inc. 13G 6.85% 2y
Almitas Capital LLC NPCT Nuveen Core Plus Impact Fund 13G 5.88% 2y
CITADEL ADVISORS LLC ARTE Artemis Strategic Investment Corporation Class A Common Stock 13G/A 0% 2y
Electron Capital Partners, LLC OPAL OPAL Fuels Inc. 13G/A 6.4% 2y
Berkshire Hathaway Inc CE Celanese Corp 13G/A 0% 2y
Avidity Partners Management LP ALT Altimmune, Inc. 13G/A 0% 2y
First Trust Capital Management L.P. HCVI Hennessy Capital Investment Corp. VI Class A Common Stock 13G 7.56% 2y